Brain, 2016 · DOI: 10.1093/brain/awv395 · Published: January 29, 2016
As we age, the central nervous system (CNS) experiences a decline in both gray and white matter, leading to cognitive impairment. This decline is often worsened by neurological disorders such as Alzheimer's disease and multiple sclerosis. Macrophages and microglia, which are immune cells in the CNS, play a role in these conditions. This article explores how macrophages and microglia age differently and how these differences impact the aging CNS. It suggests that targeting these differences with specific therapies might help rejuvenate these cells and improve neurological repair. The authors propose therapeutic strategies that selectively target these diverse mechanisms may rejuvenate macrophages and microglia for repair in the ageing central nervous system.
Developing therapies that specifically target the distinct aging mechanisms of macrophages and microglia could lead to more effective treatments for age-related neurological disorders.
Rejuvenating aging macrophage/microglia may preserve neurological integrity and promote regeneration in the ageing central nervous system.
Stimulating microglia to phagocytose inhibitory myelin debris without an excessive pro-inflammatory cytokine response could enhance axon regeneration and remyelination.